Raybow was founded in 2008 as the CDMO division of Jiuzhou Pharmaceutical to provide expert process development and manufacturing for biotech and large pharma clients. Raybow can accommodate a variety of chemistries, including high potency,and offers high quality, efficient and cost-effective services designed to accelerate the drug development process. Raybow manufactures advanced intermediates, regulatory starting materials and active pharmaceutical ingredients in a US FDA inspected facility in Taizhou, China. Client projects cover all phases of development from pre-clinical to commercial.
Raybow is happy to announce that on Monday March 2nd we restored our Chinese R&D and manufacturing sites to full capacityMar 2, 2020 | Read Story